Patient Experience Study of the MemorEM Head Device for Neurological Diseases
Gathers feedback on a head device used by people with dementia-related diseases.
Plain-language title generated from the registry record
Registry title: Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
Key facts
- Where
- Atlanta, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 100 years old?
Source: NCT07222605, who can take part
Where in United States
- CareONE ConciergeAtlanta, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- eQ8Health Corporation d/b/a CareONE Concierge
- Trial code
- NCT07222605
- Record updated
- 5 February 2026
- Original description
Primary Objective:Read full original descriptionShow less
Research Study Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
Primary Objective:
The primary objective of this pilot study is to gain voluntary feedback from patients with neurological diseases and their caregivers regarding their experiences using the MemorEM head device. This information may help in new designs of the MemorEM and suggest ways to increase compliance for future clinical trials and eventual commercialization.
Secondary Objective:
The secondary objective is to note areas of potential improvement in the progression of the subject's neurological disease and identify the potential for the MemorEM to treat neurological diseases other than Alzheimer's disease. The investigators are also interested in Alzheimer's variants like those with ApoE4 alleles (none of the participants in the 8-person pilot were Apo-E4 positive), known mutations causing early onset Alzheimer's, and Posterior Cortical Atrophy.
Inclusion: Patient diagnosed with a neurological disease involving aggregated proteins such as Alzheimer's and its variants, Parkinson's, Frontotemporal dementia, Amyotrophic lateral sclerosis, Tauopathies, and other related neurological diseases; Presence of a caregiver(s) responsible for ensuring treatment compliance and potentially with authority to make medical decisions for the patient if the patient is not competent to make those decisions; A statement from each patient's physician that indicates the patient has the ability to understand and consent on their own AND they have the willingness to sign CareONE's patient consent.
Exclusion: Presence of metal implants in the head, except for metal dental implants; Patient has implanted medication pumps unless cleared by physician; Patient has Seizures, Epilepsy, uncontrolled Depression, uncontrolled Bipolar disorder, psychotic disorders, alcoholism or drug addiction; Patient has hypertension that is unresponsive to anti-hypertensive medications; Patient has significant heart disease, as determined by a physician.